FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Valeria Bonfante

Research Profile

Disorders

Hodgkin's Disease

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Reed-Sternberg Cells

Co-author Network

Publications

TOP 3
Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Fabrizio Villani; Alessandra Busia; Massimiliano Villani; Chiara Vismara; Simonetta Viviani; Valeria Bonfante
Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease.
Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Valeria Bonfante (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Leukemia & lymphoma 2010;51(7):1251-9.
2008: Fabrizio Villani; Alessandra Busia; Massimiliano Villani; Chiara Vismara; Simonetta Viviani; Valeria Bonfante
Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease.
Tumori 2008;94(6):803-8.
2006: Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
European journal of haematology 2006;77(5):387-94.
2005: Gianni Bonadonna; Simonetta Viviani; Valeria Bonfante; ALESSANDRO MASSIMO GIANNI; Pinuccia Valagussa
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2004: Carlo Visco; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; L Jeffrey Medeiros; P Notti; George Z Rassidakis; Prema P Peethambaram; Richard Wilder; Thomas E Witzig; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Gianni Bonadonna; Valeria Bonfante; Simonetta Viviani; Anna Di Russo; Fabrizio Villani; Pinuccia Valagussa
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2835-41.
2003: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: Fabrizio Villani; A Fede Catania; Alberto Laffranchi; Lorenzo Maffioli; Simonetta Viviani; Valeria Bonfante
Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease.
Cancer investigation 2003;21(2):185-92.
2002: George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Timothy J McDonnell; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Fabrizio Villani; Giovanna Viola; Chiara Vismara; Alberto Laffranchi; Anna Di Russo; Simonetta Viviani; Valeria Bonfante
Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease.
Anticancer research 2002;22(4):2403-8.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: George Z Rassidakis; L Jeffrey Medeiros; Timothy J McDonnell; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2001: Marco Herling; George Z Rassidakis; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; ALESSANDRO MASSIMO GIANNI; SW Morris; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Leukemia & lymphoma 2001;42(5):969-79.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2000: A Santoro; Henning Bredenfeld; liliana devizzi; Hans Tesch; Valeria Bonfante; Simonetta Viviani; F Fiedler; H S Parra; C Benoehr; M Pacini; Gianni Bonadonna; Volker Diehl
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2615-9.
2000: Simonetta Viviani; P Notti; Valeria Bonfante; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Medical oncology (Northwood, London, England) 2000;17(1):59-63.
2000: Fabrizio Villani; Simonetta Viviani; Valeria Bonfante; P De Maria; F Soncini; Alberto Laffranchi
Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy alone.
American journal of clinical oncology 2000;23(1):18-21.
1999: Fabrizio Villani; I Dell'Oca; P De Maria; G Viola; Anna Di Russo; Simonetta Viviani; Valeria Bonfante
Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease.
Anticancer research 1999;19(5C):4475-9.
1999: Simonetta Viviani; Valeria Bonfante; Armando Santoro; M Zanini; liliana devizzi; Anna Di Russo; F Soncini; Fabrizio Villani; G Ragni; Pinuccia Valagussa; Gianni Bonadonna
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
The cancer journal from Scientific American 1999;5(5):275-82.
1998: Valeria Bonfante; Simonetta Viviani; Armando Santoro; liliana devizzi; Anna Di Russo; M Zanini; F Soncini; H Soto Parra; Pinuccia Valagussa; Gianni Bonadonna
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.
British journal of haematology 1998;103(2):533-5.
1998: Gianpaolo Nadali; L Tavecchia; Elisabetta Zanolin; Valeria Bonfante; Simonetta Viviani; E Camerini; P Musto; Nicola Di Renzo; Mario Carotenuto; Marco Chilosi; Mauro Krampera; Giovanni Pizzolo
Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
Blood 1998;91(8):3011-6.
1998: Simonetta Viviani; E Camerini; Valeria Bonfante; Armando Santoro; Monica Balzarotti; Monica Fornier; liliana devizzi; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
British journal of cancer 1998;77(6):992-7.
1997: Fabrizio Villani; P De Maria; Valeria Bonfante; Simonetta Viviani; Alberto Laffranchi; I Dell'oca; A Dirusso; M Zanini
Late pulmonary toxicity after treatment for Hodgkin's disease.
Anticancer research 1997;17(6D):4739-42.
1997: Valeria Bonfante; Armando Santoro; Simonetta Viviani; liliana devizzi; Monica Balzarotti; F Soncini; M Zanini; Pinuccia Valagussa; Gianni Bonadonna
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):528-34.
1997: liliana devizzi; Lorenzo Maffioli; Valeria Bonfante; Simonetta Viviani; L Balzarini; Massimo Gasparini; Pinuccia Valagussa; Emilio Bombardieri; Armando Santoro; Gianni Bonadonna
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():53-6.
1996: Monica Balzarotti; C Tondini; Valeria Bonfante; liliana devizzi; Simonetta Viviani; Monica Fornier; Armando Santoro
Lack of carboplatin activity in malignant lymphomas.
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2370-1.
1996: liliana devizzi; Armando Santoro; Valeria Bonfante; Simonetta Viviani; Gianni Bonadonna
Vinorelbine: a new promising drug in Hodgkin's disease.
Leukemia & lymphoma 1996;22(5-6):409-14.
1996: Simonetta Viviani; Gianni Bonadonna; Armando Santoro; Valeria Bonfante; M Zanini; liliana devizzi; F Soncini; Pinuccia Valagussa
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1421-30.
1994: M Zanini; Simonetta Viviani; Armando Santoro; F Soncini; Valeria Bonfante; liliana devizzi; Fabrizio Villani; Maria Rita Castellani; E Negretti; Roberto Zucali
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
International journal of radiation oncology, biology, physics 1994;30(4):813-9.
1994: liliana devizzi; Armando Santoro; Valeria Bonfante; Simonetta Viviani; L Balzarini; Pinuccia Valagussa; Gianni Bonadonna
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):817-20.
1993: Gianni Bonadonna; Luca Gianni; Armando Santoro; Valeria Bonfante; P Bidoli; P Casali; R Demicheli; Pinuccia Valagussa
Drugs ten years later: epirubicin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):359-69.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Pinuccia Valagussa; Gianni Bonadonna
ABVD in the treatment of Hodgkin's disease.
Seminars in oncology 1992;19(2 Suppl 5):38-44; discussion 44-5.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Roberto Zucali; liliana devizzi; M Zanini; J D Tesoro Tess; Pinuccia Valagussa; A Banfi; Gianni Bonadonna
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):24-9.
1991: Gianni Bonadonna; Armando Santoro; ALESSANDRO MASSIMO GIANNI; Simonetta Viviani; Salvatore Siena; Marco Bregni; Roberto Zucali; F Lombardi; Valeria Bonfante; Luca Gianni
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():9-16.
1990: Simonetta Viviani; Armando Santoro; E Negretti; Valeria Bonfante; Pinuccia Valagussa; Gianni Bonadonna
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):123-7.
1989: Gianni Bonadonna; Pinuccia Valagussa; A Santoro; Simonetta Viviani; Valeria Bonfante; A Banfi
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():169-74.
1988: E Negretti; L Ferrari; Valeria Bonfante; E Bajetta
Phase II study with ifosfamide in advanced malignant melanoma.
Tumori 1988;74(2):163-5.
1988: Fabrizio Villani; M Galimberti; R Comazzi; F Crippa; Valeria Bonfante; L Ferrari; M A Pacciarini
Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
International journal of clinical pharmacology, therapy, and toxicology 1988;26(4):185-9.
1987: A Santoro; G Bonadonna; P Valagussa; Roberto Zucali; Simonetta Viviani; Fabrizio Villani; A M Pagnoni; Valeria Bonfante; R Musumeci; F Crippa
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(1):27-37.
1986: Valeria Bonfante; L Ferrari; C Brambilla; A Rossi; Fabrizio Villani; F Crippa; P Valagussa; G Bonadonna
New anthracycline analogs in advanced breast cancer.
European journal of cancer & clinical oncology 1986;22(11):1379-85.
1986: A Santoro; Simonetta Viviani; C J Villarreal; Valeria Bonfante; A Delfino; P Valagussa; G Bonadonna
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Cancer treatment reports 1986;70(3):343-8.
1986: A Santoro; Simonetta Viviani; P Valagussa; Valeria Bonfante; G Bonadonna
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Seminars in oncology 1986;13(1 Suppl 1):23-6.
1986: C Brambilla; A Rossi; Valeria Bonfante; L Ferrari; Fabrizio Villani; F Crippa; G Bonadonna
Phase II study of doxorubicin versus epirubicin in advanced breast cancer.
Cancer treatment reports 1986;70(2):261-6.
1985: Simonetta Viviani; A Santoro; Guido Ragni; Valeria Bonfante; O Bestetti; G Bonadonna
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
European journal of cancer & clinical oncology 1985;21(5):601-5.
1985: G Bonadonna; Simonetta Viviani; P Valagussa; Valeria Bonfante; A Santoro
Third-line salvage chemotherapy in Hodgkin's disease.
Seminars in oncology 1985;12(1 Suppl 2):23-5.
1984: L Ferrari; A Rossi; C Brambilla; Valeria Bonfante; F Villani; F Crippa; G Bonadonna
Phase I study with 4'-deoxydoxorubicin.
Investigational new drugs 1984;2(3):287-95.